There were 1,884 press releases posted in the last 24 hours and 359,112 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Protalix BioTherapeutics Announces Positive Results from Phase II Clinical Trial of alidornase alfa (AIR DNase™) for the Treatment of Cystic Fibrosis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image